Myeloid Cell Sirtuin-1 Expression Does Not Alter Host Immune Responses to Gram-Negative Endotoxemia or Gram-Positive Bacterial Infection
Name
Alexander-2013-Myeloid Cell Sirtuin.pdf
Size
761.87 KB
Format
Adobe PDF
Checksum (MD5)
f52193202c4521f6a0e4d2a869639dd7
Author(s)
Crotty Alexander, Laura E.
Marsh, Brenda J.
Timmer, Anjuli M.
Lin, Ann E.
Zainabadi, Kayvan
Czopik, Agnieszka
Nizet, Victor
Guarente, Leonard Pershing
Date Issued
December 2013
Journal
PLoS ONE
Publisher
Public Library of Science
Citation
Crotty Alexander, Laura E., Brenda J. Marsh, Anjuli M. Timmer, Ann E. Lin, Kayvan Zainabadi, Agnieszka Czopik, Leonard Guarente, and Victor Nizet. “Myeloid Cell Sirtuin-1 Expression Does Not Alter Host Immune Responses to Gram-Negative Endotoxemia or Gram-Positive Bacterial Infection.” Edited by Michael B. Fessler. PLoS ONE 8, no. 12 (December 26, 2013): e84481.
Version
Final published version
Abstract
The role of sirtuin-1 (SIRT1) in innate immunity, and in particular the influence of SIRT1 on antimicrobial defense against infection, has yet to be reported but is important to define since SIRT1 inhibitors are being investigated as therapeutic agents in the treatment of cancer, Huntington’s disease, and autoimmune diseases. Given the therapeutic potential of SIRT1 suppression, we sought to characterize the role of SIRT1 in host defense. Utilizing both pharmacologic methods and a genetic knockout, we demonstrate that SIRT1 expression has little influence on macrophage and neutrophil antimicrobial functions. Myeloid SIRT1 expression does not change mortality in gram-negative toxin-induced shock or gram-positive bacteremia, suggesting that therapeutic suppression of SIRT1 may be done safely without suppression of myeloid cell-specific immune responses to severe bacterial infections.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1371/journal.pone.0084481
